Invention Grant
US08722682B2 Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
有权
具有混合血清素受体亲和力的硫酸化苯并咪唑酮衍生物
- Patent Title: Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
- Patent Title (中): 具有混合血清素受体亲和力的硫酸化苯并咪唑酮衍生物
-
Application No.: US12518574Application Date: 2007-12-18
-
Publication No.: US08722682B2Publication Date: 2014-05-13
- Inventor: Astrid Volz , Ralf Lotz , Fabio Paleari
- Applicant: Astrid Volz , Ralf Lotz , Fabio Paleari
- Applicant Address: US NC Raleigh
- Assignee: Sprout Pharmaceuticals, Inc.
- Current Assignee: Sprout Pharmaceuticals, Inc.
- Current Assignee Address: US NC Raleigh
- Agency: Additon, Higgins, Pendleton & Ashe, P.A.
- Priority: EP06126689 20061220
- International Application: PCT/EP2007/064120 WO 20071218
- International Announcement: WO2008/074795 WO 20080626
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D235/26
Abstract:
The present invention pertains to a compound of formula (I) wherein R1, R2, R3, and R4 are each hydrogen or sulfate monoester with the proviso that R1, R2, R3, and R4 cannot simultaneously be hydrogen, processess for their preparation and their use as pharmaceuticals in the treatment of CNS disorders.
Public/Granted literature
- US20110015207A1 SULFATED BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE RECEPTOR AFFINITY Public/Granted day:2011-01-20
Information query
IPC分类:
